Coronavirus in human diseases: Mechanisms and advances in clinical treatment

被引:20
|
作者
Lin, Panpan [1 ]
Wang, Manni [1 ]
Wei, Yuquan [1 ]
Kim, Taewan [2 ]
Wei, Xiawei [1 ]
机构
[1] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Lab Aging Res & Canc Drug Target,State Key Lab Bi, Chengdu 610041, Peoples R China
[2] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
来源
MEDCOMM | 2020年 / 1卷 / 03期
关键词
clinical treatments; COVID-19; human coronaviruses; MERS; SARS; RESPIRATORY SYNDROME CORONAVIRUS; INFECTIOUS-BRONCHITIS-VIRUS; PAPAIN-LIKE PROTEASE; RECEPTOR-BINDING DOMAIN; ANGIOTENSIN-CONVERTING ENZYME; SARS-ASSOCIATED CORONAVIRUS; INNATE ANTIVIRAL RESPONSE; HUMAN MONOCLONAL-ANTIBODY; DIPEPTIDYL-PEPTIDASE IV; SMALL MEMBRANE-PROTEIN;
D O I
10.1002/mco2.26
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Coronaviruses (CoVs), a subfamily of coronavirinae, are a panel of single-stranded RNA virus. Human coronavirus (HCoV) strains (HCoV-229E, HCoV-OC43, HCoV-HKU1, HCoV-NL63) usually cause mild upper respiratory diseases and are believed to be harmless. However, other HCoVs, associated with severe acute respiratory syndrome, Middle East respiratory syndrome, and COVID-19, have been identified as important pathogens due to their potent infectivity and lethality worldwide. Moreover, currently, no effective antiviral drugs treatments are available so far. In this review, we summarize the biological characters of HCoVs, their association with human diseases, and current therapeutic options for the three severe HCoVs. We also highlight the discussion about novel treatment strategies for HCoVs infections.
引用
收藏
页码:270 / 301
页数:32
相关论文
共 50 条
  • [1] RECENT CLINICAL ADVANCES IN TREATMENT OF NEUROLOGICAL DISEASES
    FENICHEL, GM
    PEDIATRIC CLINICS OF NORTH AMERICA, 1970, 17 (02) : 323 - +
  • [2] Clinical Advances in the Diagnosis and Treatment of Cerebrovascular Diseases
    Lak, Asad
    Zanaty, Mario
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [3] Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
    Wu, Yan-Lin
    Lin, Zheng-Jun
    Li, Chang-Chun
    Lin, Xiao
    Shan, Su-Kang
    Guo, Bei
    Zheng, Ming-Hui
    Li, Fuxingzi
    Yuan, Ling-Qing
    Li, Zhi-hong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [4] Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
    Jiang, Qiu
    Liu, Jie
    Huang, Shan
    Wang, Xuan-Yue
    Chen, Xiaowei
    Liu, Guang-Hui
    Ye, Keqiang
    Song, Weihong
    Masters, Colin L.
    Wang, Jun
    Wang, Yan-Jiang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [5] Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
    Yan-Lin Wu
    Zheng-Jun Lin
    Chang-Chun Li
    Xiao Lin
    Su-Kang Shan
    Bei Guo
    Ming-Hui Zheng
    Fuxingzi Li
    Ling-Qing Yuan
    Zhi-hong Li
    Signal Transduction and Targeted Therapy, 8
  • [6] Clinical Advances in the Diagnosis and Treatment of Biliary Tract Diseases
    Matsubara, Saburo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [7] Mechanisms and advances in allergic diseases
    Busse, WW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (06) : S593 - S598
  • [8] Advances in the pharmacological effects and molecular mechanisms of emodin in the treatment of metabolic diseases
    Yu, Linyuan
    Zhao, Yongliang
    Zhao, Yongli
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] Clinical research advances of isavuconazole in the treatment of invasive fungal diseases
    Zhang, Tingting
    Shen, Yuyan
    Feng, Sizhou
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [10] Special Issue "Clinical Advances in Chronic Intestinal Diseases Treatment"
    Latorre, Eva
    Emilio Mesonero, Jose
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)